Trial
NCT00383630
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Heart Failure, Congestive
Intervention
Intramyocardial injection of bone marrow mononuclear cells
Why stopped
Terminated due to logistical barriers to cell processing and poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-17